In market terms, one of the natural side effects of the COVID-19 health crisis has been an elevated focus on stocks in the Healthcare sector. That covers a wide range of industries, from health insurance to biopharmaceutical and healthcare equipment and supplies. All of these companies have spent the last eighteen months not only coping […]
Read MoreEver since coronavirus found its way to American shores, a lot of media attention has been given to the Healthcare sector – and especially to the Biotechnology industry, where many of the biggest names across the world have been working hard to develop effective treatments for the disease. As of this writing, vaccinations have steadily […]
Read MoreFor the past year, one of the most interesting storylines has been not only how corporations have evolved to survive and get by, but also how consumer behaviors and trends have adjusted as well. Broad-based shutdowns that shuttered businesses all over the U.S. at the beginning of the pandemic sent people home for an indefinite […]
Read MoreEver since coronavirus found its way to American shores, a lot of media attention has been given to the Healthcare sector – and especially to the Biotechnology industry, where many of the biggest names across the world have been working hard to develop effective treatments for the disease. From the market’s bearish low in mid-March, […]
Read MoreI tend to take most of the information I get from news media with a large grain of salt. That is especially true of market media outlets, which have so much information to try to report about on a daily basis that they really can’t do much more than talk about whatever happens to be […]
Read MoreThere is a lot of fundamental data that I rely on to help paint an overall picture about underlying strength of any stock I might consider using for a value-based investment. While some fundamental investors prefer to work with easy-to-reference, quick-glance data like earnings per share, I prefer to expand my view of a company’s […]
Read MoreFor most of the past year, any examination of the Pharmaceutical industry begins and ends with COVID-19 vaccines. Literally, of course, this isn’t true; diseases of all kinds don’t take a holiday during a pandemic, and so development of existing projects for any company in this industry hasn’t stopped, either. Nonetheless, the massive, immediate impact […]
Read MoreSince the beginning of the year, broad market momentum has mostly stalled. Investors seem to be confronting the reality that the pandemic’s economic effects appear set to linger well into the rest of this year, even as vaccinations across the country begin to increase and new vaccine candidates appear ready to apply for emergency use […]
Read MorePlus, the NYSE reversed course on their decision to not delist three Chinese telecoms, bitcoin rose to another new all-time high, and UnitedHealth is buying Change Healthcare.
Read MoreWith thousands of publicly available stocks to work with, the question most investors face when looking for ways to keep their money working for them isn’t really about which stocks they might be able to use. I’ve spent more than two decades watching the markets and studying different investing and trading styles and methods. What […]
Read MoreThe Consumer Discretionary sector includes stocks that cover a wide variety of the Retail industry. Because there are so many retail companies that offer different products to consumers, it’s hard to pinpoint any kind of specific niche. In the sporting goods niche, there were significant challenges even before COVID-19 became a global pandemic. Declining revenues […]
Read MoreEver since coronavirus found its way to American shores, a large amount of media attention has been given to the Healthcare sector – and especially to the Biotechnology industry, where many of the biggest names across the world have been working hard to develop effective treatments for the disease. From the market’s bearish low in […]
Read MoreI hope everybody had a wonderful Thanksgiving holiday! I’ve written a lot in this space about my belief in defensive sectors and industries for more than a year now. The market is showing a lot of bullish momentum right now, but I think the initial relief that I attribute mostly to decreasing political uncertainty is […]
Read MoreOne of the most straightforward and useful ways for average investors like you and me to maintain an active investing approach without drowning in the massive volumes of news reports, analyst opinions and buzz around the thousands of publicly traded stocks is to work with our own watchlists. These are lists of stocks that you […]
Read MorePost-election, a lot of the focus for the markets has, not surprisingly shifted back to COVID and the pandemic that just won’t stop. Concern is increasing that the colder months of the year will make things even worse, and that a health care system that is already being strained as infections and hospitalizations are pushing […]
Read More